Cas:2393-17-1 3-(4-Aminophenyl)propionic acid manufacturer & supplier

Chemical Name:3-(4-Aminophenyl)propionic acid

CAS.NO:2393-17-1

Synonyms:4-Aminohydrocinnamic Acid;3-(4-Aminophenyl)propanoic acid;Benzenepropanoic acid, 4-amino-;EINECS 219-245-1;4-aminobenzenepropanoic acid;3-(4-Aminophenyl)propionic Acid;MFCD00017118;Benzenepropanoic acid,4-amino;para-aminophenylpropionic acid

Molecular Formula:C₉H₁₁NO₂

Molecular Weight:165.189

HS Code:2922499990

Physical and Chemical Properties:

Melting point:133-137 °C(lit.)

Boiling point:351.0±17.0 °C at 760 mmHg

Density:1.2±0.1 g/cm3

Index of Refraction:1.597

PSA:63.32000

Exact Mass:165.078979

LogP:0.56

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 4-Aminohydrocinnamic Acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,para-aminophenylpropionic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Aminohydrocinnamic Acid Use and application,EINECS 219-245-1 technical grade,usp/ep/jp grade.

Related News: On Friday, the Trump administration announced it will deny entry to foreign nationals who have traveled in China in the last 14 days, starting Sunday. 3-(4-Aminophenyl)propionic acid manufacturer Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML). 3-(4-Aminophenyl)propionic acid supplier At present, Teva can produce more than 300 generic drugs, and the API department has approximately 650 authorized patents and patent applications worldwide. It is also the generic drug company with the most challenges in patenting ParagraphIV in the world. 3-(4-Aminophenyl)propionic acid vendor Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML). 3-(4-Aminophenyl)propionic acid factory Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).